Clinical aggressiveness and long-term outcome in patients with papillary thyroid cancer and circulating anti-thyroglobulin autoantibodies

Thyroid

Volumn 24, Issue 7, 2014, Pages 1139-1145

  Durante, Cosimo ^a   Tognini, Sara ^b   Montesano, Teresa ^a   Orlandi, Fabio ^c   Torlontano, Massimo ^d   Puxeddu, Efisio ^e   Attard, Marco ^f   Costante, Giuseppe ^g,h   Tumino, Salvatore ⁱ   Meringolo, Domenico ^j   Bruno, Rocco ^k   Trulli, Fabiana ^a   Toteda, Maria ^a   Redler, Adriano ^a   Ronga, Giuseppe ^a   Filetti, Sebastiano ^a   Monzani, Fabio ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^e UNIVERSITY OF PERUGIA   (Italy)

^f Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello   (Italy)

^g UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^h JULES BORDET INSTITUTE   (Belgium)

ⁱ UNIVERSITY OF CATANIA   (Italy)

^j Ospedale di Bentivoglio   (Italy)

^k Tinchi Pisticci Hospital   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; RADIOACTIVE IODINE; THYROGLOBULIN ANTIBODY; ANTI-THYROGLOBULIN; AUTOANTIBODY; THYROGLOBULIN;

ABLATION THERAPY; ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BONE METASTASIS; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CERVICAL LYMPH NODE; CHEMOEMBOLIZATION; CHILD; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISTANT METASTASIS; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM METASTASIS; OUTCOME ASSESSMENT; PAPILLARY THYROID CANCER; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THYROID CANCER; THYROID GLAND; THYROIDECTOMY; BLOOD; CLINICAL TRIAL; IMMUNOLOGY; MIDDLE AGED; MULTICENTER STUDY; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROGNOSIS; THYROID NEOPLASMS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; THYROGLOBULIN; THYROID NEOPLASMS; THYROIDECTOMY; YOUNG ADULT;

EID: 84903961683     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2013.0698     Document Type: Article

References (29)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ 2006 Cancer Statistics, 2006. CA Cancer J Clin 56:106-130
2. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214
3. Spencer CA 2011 Clinical review: Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC). J Clin Endocrinol Metab 96:3615-3627
4. Rubello D, Casara D, Girelli ME, Piccolo M, Busnardo B 1992 Clinical meaning of circulating antithyroglobulin antibodies in Differentiated thyroid cancer: A prospective study. J Nucl Med 33:1478-1480
5. Chung JK, Park YJ, Kim TY, So Y, Kim SK, Park DJ, Lee DS, Lee MC, Cho BY 2002 Clinical significance of elevated level of serum antithyroglobulin antibody in patients with differentiated thyroid cancer after thyroid ablation. Clin Endocrinol (Oxf) 57:215-221
6. Adil A, Jafri RA, Waqar A, Abbasi SA, Matiul-Haq, Asghar AH, Jilani A, Naz I 2003 Frequency and clinical importance of anti-Tg auto-Antibodies (ATG). J Coll Physicians Surg Pak 13:504-506
7. Kim WG, Yoon JH, Kim WB, Kim TY, Kim EY, Kim JM, Ryu JS, Gong G, Hong SJ, Shong YK 2008 Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 93:4683-4689
8. Tsushima Y, Miyauchi A, Ito Y, Kudo T, Masuoka H, Yabuta T, Fukushima M, Kihara M, Higashiyama T, Takamura Y, Kobayashi K, Miya A, Kikumori T, Imai T, Kiuchi T 2013 Prognostic significance of changes in serum thyroglobulin antibody levels of pre- And posttotal thyroidectomy in thyroglobulin antibody-positive papillary thyroid carcinoma patients. Endocr J 60:871-876
9. Kumar A, Shah DH, Shrihari U, Dandekar SR, Vijayan U, Sharma SM 1994 Significance of antithyroglobulin autoantibodies in Differentiated thyroid carcinoma. Thyroid 4:199-202
10. Görges R, Maniecki M, Jentzen W, Sheu SN, Mann K, Bockisch A, Janssen OE 2005 Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomy. Eur J Endocrinol 153:49-55
11. Grebe SK 2010 Thyroglobulin autoantibodies, thyroid nodules, and new insights into some old questions. Thyroid 20:841-842
12. Muzza M, Degl'Innocenti D, Colombo C, Perrino M, Ravasi E, Rossi S, Cirello V, Beck-Peccoz P, Borrello MG, Fugazzola L 2010 The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: Clinical and molecular studies. Clin Endocrinol (Oxf):702-708
13. Caturegli P, De Remigis A, Chuang K, Dembele M, Iwama A, Iwama S 2013 Hashimoto's thyroiditis: Celebrating the centennial through the lens of the Johns Hopkins hospital surgical pathology records. Thyroid 23:142-150
14. Jankovic B, Le KT, Hershman JM 2013 Clinical Review: Hashimoto's thyroiditis and papillary thyroid carcinoma: Is there a correlation?. J Clin Endocrinol Metab 98:474-482
15. Lee JH, Kim Y, Choi JW, Kim YS 2013 The association between papillary thyroid carcinoma and histologically proven Hashimoto's thyroiditis: A meta-Analysis. Eur J Endocrinol 168:343-349
16. Kim KW, Park YJ, Kim EH, Park SY, Park do J, Ahn SH, Park do J, Jang HC, Cho BY 2011 Elevated risk of papillary thyroid cancer in Korean patients with Hashimoto's thyroiditis. Head Neck 33:691-695
17. Ahn D, Heo SJ, Park JH, Kim JH, Sohn JH, Park JY, Park SK, Park J 2011 Clinical relationship between Hashimoto's thyroiditis and papillary thyroid cancer. Acta Oncol 50: 1228-1234
18. Yoon YH, Kim HJ, Lee JW, Kim JM, Koo BS 2012 The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis. Eur Arch Otorhinolaryngol 269:1013-1017
19. Dvorkin S, Robenshtok E, Hirsch D, Strenov Y, Shimon I, Benbassat CA 2013 Differentiated thyroid cancer is associated with less aggressive disease and better outcome in patients with coexisting Hashimotos thyroiditis. J Clin Endocrinol Metab 98:2409-2414
20. McLeod DS, Cooper DS, Ladenson PW, Ain KB, Brierley JD, Fein HG, Haugen BR, Jonklaas J, Magner J, Ross DS, Skarulis MC, Steward DL, Maxon HR, Sherman SI for The National Thyroid Cancer Treatment Cooperative Study Group 2014 Prognosis of differentiated thyroid cancer in relation to serum TSH and thyroglobulin antibody status at time of diagnosis. Thyroid 24:35-42
21. Durante C, Montesano T, Torlontano M, Attard M, Monzani F, Tumino S, Costante G, Meringolo D, Bruno R, Trulli F, Massa M, Maniglia A, D'Apollo R, Giacomelli L, Ronga G, Filetti S; PTC Study Group 2013 Papillary thyroid cancer: Time course of recurrences during postsurgery surveillance. J Clin Endocrinol Metab 98:636-642
22. Cunha LL, Ferreira RC, Marcello MA, Vassallo J, Ward LS 2011 Clinical and pathological implications of concurrent autoimmune thyroid disorders and papillary thyroid cancer. J Thyroid Res 2011:387062
23. Benvenga S 2013 On the association between Hashimoto's thyroiditis and papillary thyroid carcinoma. Looking 100 years back and, hopefully, fewer years ahead to sort out this association. Thyroid 23:1180-1181
24. Asanuma K, Sugenoya A, Kasuga Y, Itoh N, Kobayashi S, Amano J 1998 The relationship between multiple intrathyroidal involvement in papillary thyroid carcinoma and chronic non-specific thyroiditis. Cancer Lett 122:177-180
25. Kim EY, Kim WG, Kim WB, Kim TY, Kim JM, Ryu JS, Hong SJ, Gong G, Shong YK 2009 Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma. Clin Endocrinol 71:581-586
26. Kim HS, Choi YJ, Yun JS 2010 Features of papillary thyroid microcarcinoma in the presence and absence of lymphocytic thyroiditis. Endocr Pathol 21:149-153
27. Kebebew E, Treseler PA, Ituarte PH, Clark OH 2001 Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited. World J Surg 25:632-637
28. Latrofa F, Ricci D, Grasso L, Vitti P, Masserini L, Basolo F, Ugolini C, Mascia G, Lucacchini A, Pinchera A 2008 Characterization of thyroglobulin epitopes in patients with autoimmune and non-Autoimmune thyroid diseases using recombinant human monoclonal thyroglobulin autoantibodies. J Clin Endocrinol Metab 93:591-596
29. Chiovato L, Latrofa F, Braverman LE, Pacini F, Capezzone M, Masserini L, Grasso L, Pinchera A 2003 Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Intern Med 139:346-351